This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Stocks Rising on Unusual Volume


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Incyte (INCY - Get Report) is a drug discovery and development company, focused on developing small molecule drugs to treat serious unmet medical needs. This stock is trading up 6% at $14.43 in recent trading.

Today's Volume: 1.2 million shares

Average Volume: 2 million shares

Volume % Change: 50%

From a technical standpoint, INCY has started to spike back above its 50-day moving average of $13.75 on decent volume.

Market players should now watch for a sustained high-volume move and close above its next significant overhead resistance levels at 14.72 to $14.75. Look for volume above those levels that tracks in close to or above 2 million. If we get that action, then look for this stock to re-test $15.49 to $15.94 (its 200-day) in the near future.

Incyte shows up on a list of 10 Biotech Stocks Loved and Hated by the Pros.
5 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
BYI $83.27 0.00%
AZO $765.23 0.00%
ENDP $27.00 0.00%
INCY $72.27 0.00%
MIND $3.72 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs